Skip to main content
. 2023 Jul 24;10:1105981. doi: 10.3389/fmed.2023.1105981

Table 5.

Treatment safety evaluation between grous.

Adverse effect Patients with q8w/q4w SC (n = 105) Patients with IV reinduction (n = 23) p value
Allergy (n/n,%) 1/105 (1.0) 1/23 (4.3) 0.236
Pruritis (n/n,%) 3/105 (2.9) 0/23 (0) 0.414
Total (n/n,%) 4/105 (3.8) 1/23 (4.3) 0.904